en · de · es
sr9009-notes.peptides7501.com › Guide › Background And Research Status — Questions and Answers

Background And Research Status — Questions and Answers

By Editorial Desk · published 2025-08-04 · last reviewed 2025-09-08 · Guide

The short version of REV-ERB fits in a sentence. The long version — which is the one that helps — is below.

This page was last updated on 2025-09-08 and is reviewed periodically as new material appears.

Background and Research Status

Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.

REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.

Mechanism and Preclinical Findings

The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.

SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.

Sr9009 at a glance

PropertyValueNotes
Common nameSR9009Also referred to as Stenabolic in non-scientific contexts.
Chemical classSynthetic small moleculeNot a steroid or peptide hormone.
Receptor targetREV-ERBα and REV-ERBβNuclear receptor agonist in preclinical studies.
Development statusInvestigationalNo approved human therapeutic indication.
Regulatory attentionProhibited in sportListed by anti-doping authorities.

Detection, Regulation, and Misconceptions

Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.

Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.

Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.

Related pages on this site

Reference notes

The size and location put a person at risk of abnormal heart rhythms (arrhythmias) or heart block, aneurysm of the heart ventricles, inflammation of the heart wall following infarction, and rupture of the heart wall that can have catastrophic consequences. Injury to the myocardium also occurs during reperfusion. This might manifest as ventricular arrhythmia. Reperfusion injury results from influx of calcium and sodium into cardiac cells and the release of oxygen free radicals. The no-reflow phenomenon (when blood remains unable to perfuse the affected myocardium despite clearing the occlusion) also contributes to myocardial injury. Local endothelial swelling is one of many factors contributing to this phenomenon.

Excerpts appearing later that year on the Showtime cable network included a performance of "China Grove". The successful 1987 reunion sparked discussions about reconstituting the band on a permanent basis. They eventually decided to replicate the Toulouse Street/The Captain and Me incarnation, settling on a lineup featuring Johnston, Simmons, Hartman, Porter and Hossack, plus more recent addition LaKind, and released Cycles on Capitol Records in 1989. The album featured a Top 10 single, "The Doctor". The song is very similar to "China Grove", and the connection was further enhanced by guest Bill Payne's tinkling piano. Other material on the album included Johnston's "South of the Border", Dale Ockerman's and Pat Simmons' "Take Me to the Highway", and "I Can Read Your Mind", a version of the Isley Brothers' "Need a Little Taste of Love", and a version of the Four Tops classic, "One Chain (Don't Make No Prison)", which had been covered by Santana years before. Cycles proved a successful comeback album and was certified Gold. Bumpus participated in the 1989 and 1990 tours, adding his distinctive voice, keyboards, saxophone and flute. His presence bridged the gap between the current band and the McDonald era; he sang lead vocals on "One Step Closer" (as he originally had on the 1980 album) while Simmons took McDonald's part. The group was further augmented on the 1989 tour by Dale Ockerman (keyboards, guitar, backing vocals), Richard Bryant (percussion, vocals) and Jimi Fox (percussion, backing vocals).

=== Batteries === Due to their high energy density and the availability of sulfur, there is ongoing research in creating rechargeable lithium–sulfur batteries. Until now, carbonate electrolytes have caused failures in such batteries after a single cycle. In February 2022, researchers at Drexel University have not only created a prototypical battery that lasted 4000 recharge cycles, but also found the first monoclinic gamma sulfur that remained stable below 95 degrees Celsius.

50S is the larger subunit of the 70S ribosome of prokaryotes, i.e. bacteria and archaea. It is the site of inhibition for antibiotics such as macrolides, chloramphenicol, clindamycin, and the pleuromutilins. It includes the 5S ribosomal RNA and 23S ribosomal RNA. Despite having the same sedimentation rate, bacterial and archaeal ribosomes can be quite different.

Latent antithrombin on formation immediately links to a molecule of native antithrombin to form the heterodimer, and it is not until the concentration of latent antithrombin exceeds 50% of the total antithrombin that it can be detected analytically. Not only is the latent form of antithrombin inactive against its target coagulation proteases, but its dimerisation with an otherwise active native antithrombin molecule also results in the native molecules inactivation. The physiological impact of the loss of antithrombin activity either through latent antithrombin formation or through subsequent dimer formation is exacerbated by the preference for dimerisation to occur between heparin activated β-antithrombin and latent antithrombin as opposed to α-antithrombin. A form of antithrombin that is an intermediate in the conversion between native and latent forms of antithrombin has also been isolated and this has been termed prelatent antithrombin.

Sources: en.wikipedia.org

Notes from published material

== Toxicity == Lectins are one of many toxic constituents of many raw plants that are inactivated by proper processing and preparation (e.g., cooking with heat, fermentation). For example, raw kidney beans naturally contain toxic levels of lectin (e.g. phytohaemagglutinin). Adverse effects may include nutritional deficiencies, and immune (allergic) reactions.

=== Catabolism === Catabolism is the metabolic reaction which cells undergo to break down larger molecules, extracting energy. There are two major metabolic pathways of monosaccharide catabolism: glycolysis and the citric acid cycle. In glycolysis, oligo- and polysaccharides are cleaved first to smaller monosaccharides by enzymes called glycoside hydrolases. The monosaccharide units can then enter into monosaccharide catabolism. A 2 ATP investment is required in the early steps of glycolysis to phosphorylate Glucose to Glucose 6-Phosphate (G6P) and Fructose 6-Phosphate (F6P) to Fructose 1,6-biphosphate (FBP), thereby pushing the reaction forward irreversibly. In some cases, as with humans, not all carbohydrate types are usable as the digestive and metabolic enzymes necessary are not present.

== Disease relevance == E3 ubiquitin ligases regulate homeostasis, cell cycle, and DNA repair pathways, and as a result, a number of these proteins are involved in a variety of cancers, including famously MDM2, BRCA1, and Von Hippel-Lindau tumor suppressor. For example, a mutation of MDM2 has been found in stomach cancer, renal cell carcinoma, and liver cancer (amongst others) to deregulate MDM2 concentrations by increasing its promoter's affinity for the Sp1 transcription factor, causing increased transcription of MDM2 mRNA. Several proteomics-based experimental techniques are available for identifying E3 ubiquitin ligase-substrate pairs, such as proximity-dependent biotin identification (BioID), ubiquitin ligase-substrate trapping, and tandem ubiquitin-binding entities (TUBEs).

Regardless of the flow assumptions, a statement of the conservation of mass is generally necessary. This is achieved through the mass continuity equation, as discussed above in the "General continuum equations" within this article, as follows:

Sections of human skin can be found in the collections of some museums. Some examples of this include books bound with human skin (anthropodermic bibliopegy) and preserved tattoos. The largest collection of the latter can be found in the Wellcome Collection at the Science Museum, London. American artist Andrew Krasnow has caused controversy in recent decades by creating pieces of contemporary art made of human skin. His works, which often make political statements, are composed of pieces of flesh from individuals who have donated their bodies to science. The skin itself has been preserved by tanning.

Sources: en.wikipedia.org

Background from the literature

In November 2023, the two debated, with Fox News's Sean Hannity as moderator. In July 2024, Newsom launched a podcast, Politickin', co-hosted by Marshawn Lynch and Doug Hendrickson. After Biden's sudden withdrawal from the presidential race that month, Newsom said he would not seek the Democratic nomination, and endorsed Vice President Kamala Harris for president. After Donald Trump won the 2024 election, Newsom called for California lawmakers to convene later in 2024 to safeguard California's policies from the second Trump administration. In December 2024, Newsom criticized Biden for pardoning his son Hunter, saying, "I'm disappointed and can't support the decision." Since the 2024 U.S. presidential election, Newsom has repeatedly declined to identify himself with either the progressive or moderate faction of the Democratic Party, calling such labels "reductive" and calling himself a "hard-headed pragmatist". He said he wants the Democratic Party to be an "inclusive" big tent, spanning the ideological spectrum "from Manchin to Mamdani". In August 2025, Newsom began communicating on social media platforms in a style intended to mock Trump's style of online communication. In June 2026, Newsom said the United States Department of Justice was prosecuting him and his wife at Trump's direction.

I have not found a "smoking gun" which shows that Mr Galloway has, personally and directly, unlawfully received moneys from the former Iraqi regime. However I have amassed a very substantial body of evidence from a variety of sources which is generally internally consistent and, in my view: a) Clearly shows that Mr Galloway's anti-sanctions work through the Mariam Appeal was in effect supported by the former Iraqi regime, through Mr Fawaz Zureikat and using, among other things, the mechanism of the Oil for Food Programme. b) Clearly shows that Mr Galloway at best turned a blind eye to the fact that this was happening.

Juice is a drink made from the extraction or pressing of the natural liquid contained in fruit and vegetables. It can also refer to liquids that are flavored with concentrate or other biological food sources like meat or seafood, such as clam juice. Juice is commonly consumed as a beverage or used as an ingredient or flavoring in foods or other beverages, such as smoothies. Juice emerged as a popular beverage choice after the development of pasteurization methods enabled its preservation without using fermentation (which is used in wine production). The largest fruit juice consumers are New Zealand (nearly a cup, or 8 ounces, each day) and Colombia (more than three quarters of a cup each day). Fruit juice consumption on average increases with a country's income level.

Following the success of Counter-Strike, Valve went on to release multiple installments in the series. The first subsequent game, Counter-Strike: Condition Zero, which used Counter-Strike's GoldSrc engine, was released in 2004. Counter-Strike: Source, a remake of the original Counter-Strike, was the first game in the series to use Valve's Source engine and was also released in 2004, eight months after the release of Condition Zero. The next game in the Counter-Strike series was Counter-Strike: Global Offensive, released for Windows, OS X, Linux, PlayStation 3, and Xbox 360 in 2012. Counter-Strike 2, an updated version of Global Offensive, was released in 2023. The game spawned multiple spin-offs for the Asian gaming market. The first, Counter-Strike Neo, was an arcade game developed by Namco and released in Japan in 2003. In 2008, Nexon Corporation released Counter-Strike Online, a free-to-play installment in the series monetized via microtransactions. Counter-Strike Online was followed by Counter-Strike Online 2 in 2013. In 2014, Nexon released Counter-Strike Nexon: Zombies worldwide via Steam.

Sources: en.wikipedia.org

Frequently asked questions

What is SR9009?

It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.

Is SR9009 a steroid?

No. It is a small molecule that binds nuclear receptors involved in circadian regulation. Its classification differs from anabolic steroids or peptide hormones.

Has SR9009 been tested in humans?

Published human clinical trial data are lacking. Most safety and activity information comes from preclinical models, so effects in people remain uncertain.

What is SR9009?

It is a synthetic compound that acts as an agonist at REV-ERBα and REV-ERBβ. It is used mainly as a research chemical to study circadian and metabolic pathways. It is not approved for human therapeutic use.

Network